The Forefront of Cancer Treatment & Research

This cutting edge translation medicine unit focuses on research and treatment using cell therapies to treat cancer. Often called bench to bedside, translational medicine accelerates the conversion of basic laboratory discoveries into clinical applications, diagnostics, and therapeutics to improve patient care. It connects laboratory researchers with clinicians to create a bidirectional flow of information, ensuring scientific findings directly address medical needs and that clinical observations inform future research.

The project includes a 14 bay hemapheresis patient unit directly adjacent to a Cell Therapy research laboratory suite. The unit supports the research and production of 361 and 351 HCT/P products including HPC apheresis, cord,marrow and a variety of more than minimally manipulated cellular products. Within the design for Cell Therapy suite are six (6) ISO7 labs, anterooms, airlocks, and cryogenic storage facility, which underwent an extensive review with the FDA for approval.